Investigational dose of oral interferon-free treatment can cure hepatitis C in children
by Press Release from Outbreak News Today on (#2M047)
A study that evaluated an investigational dosage of once-daily ledipasvir 45 mg/sofosbuvir 200 mg (LDV/SOF) in children aged six to 11 years infected with the Hepatitis C virus (HCV), found that 99% of children (n=89/90) had undetectable levels of HCV-RNA 12 weeks after treatment. The study, presented at The International Liver Congressa 2017 in Amsterdam, ["]
The post Investigational dose of oral interferon-free treatment can cure hepatitis C in children appeared first on Outbreak News Today.